2000L Scale GMP AAV Manufacturing Process Guidelines Using FectoVIR®-AAV
Source: Polyplus
The development of robust, scalable, cost-effective processes that yield high titers of high-quality viral vectors will be crucial to the successful commercialization of safe and efficacious gene therapies that require large and/or multiple doses to treat more prevalent diseases. Here we provide manufacturing process guidelines for scaling up your AAV production.
access the Infographic!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Polyplus
This website uses cookies to ensure you get the best experience on our website. Learn more